Anderson M H, Camm A J
St. George's Hospital Medical School, London, England.
Am Heart J. 1994 Apr;127(4 Pt 2):1185-93. doi: 10.1016/0002-8703(94)90108-2.
Automobile driving is essential to work and leisure for many people, and patients with implantable cardioverter defibrillators (ICDs) are no exception. Whether patients who may suffer sudden incapacitation should be allowed to drive raises important ethical and legal issues. The opinion of physicians regarding when or if it is safe to drive with an ICD varies, and most countries have no regulations to assist such decisions. Such regulations can best be developed by actuarial analysis of the risks involved, although the limited volume of published data on the ICD hinders this process. A policy based on very low levels of social risk from driving by patients with ICDs or a comparison with epileptic patients suggests a ban on driving for 12 to 24 months after ICD implantation. Patients who have received therapy from the ICD within this period would not be granted a driver's licence. As further data from actuarial studies become available, these guidelines could be relaxed for patients at low risk of therapy delivery.
对许多人来说,汽车驾驶对于工作和休闲都至关重要,植入式心脏复律除颤器(ICD)患者也不例外。对于可能会突然丧失行为能力的患者是否应该允许其驾驶,引发了重要的伦理和法律问题。医生对于何时或使用ICD驾驶是否安全的看法各不相同,而且大多数国家没有相关规定来辅助此类决策。尽管关于ICD的已发表数据量有限阻碍了这一过程,但此类规定最好通过对所涉风险的精算分析来制定。基于ICD患者驾驶带来的极低社会风险水平的政策,或与癫痫患者的比较表明,在ICD植入后12至24个月内应禁止驾驶。在此期间接受过ICD治疗的患者将不会获得驾驶执照。随着精算研究的更多数据可用,对于治疗风险较低的患者,这些指导原则可能会放宽。